A Sydney-based Team Turning Advanced Material Science into Better Delivery
OUR COMPANY
EncapSolutions was founded in 2022 by scientists and entrepreneurs who believed the transdermal patch industry had a delivery problem, not a molecule problem. Since then we've built our own manufacturing capability, our own IP, and a team built to take a platform technology from laboratory to market and beyond.
LEADERSHIP TEAM
Decades of experience. One platform.
A founder-led team with deep domain expertise in drug delivery science, materials engineering, and commercialisation — supported by advisors who've operated at the highest levels of pharmaceutical and consumer health.
Dr Chris Barbé
PhD-qualified scientist with more than 25 years in technology commercialisation across materials science, pharmaceutical delivery, and consumer health. Leads strategy, investor relations, and pharmaceutical partnership development. Founder and principal capital contributor to the company's development to date.
Dr Aparajita Khatri
More than 25 years in therapeutics, drug delivery science and dermal systems across academic research and applied pharmaceutical development. Leads all scientific development, formulation work, in-vitro permeation studies, and technical due diligence for licensing and manufacturing partners.
Marie Barbé
More than 25 years in marketing, communications, and brand strategy across consumer health, lifestyle, and professional services sectors. Leads brand strategy, consumer positioning, and the direct-to-consumer channel.
OUR AIM
A team united by one question: does it help people feel better?
ADVISORY BOARD
Guided by people who've done this before.
Our advisory board brings direct experience in pharmaceutical licensing, international channel development, and manufacturing scale-up — the exact disciplines our next stage of growth depends on.
Nigel Pollard
Global natural health industry leader and former pharmaceutical executive with extensive experience in channel development, international expansion, and strategic partnership formation across Australian, U.S., and international markets.
Dr Phil Kearney
Pharmaceutical licensing expert with deep experience in intellectual property strategy, licensing structure design, and partnership development — advising on the architecture of per-indication licensing agreements and royalty structures.
Dr Francis Scanlan
PhD chemist with more than 25 years across phyto-pharmaceuticals, global manufacturing, and premium consumer brands. Former SVP Global Technical at Gruppo Campari; Founder of Cloud 9 Switzerland.
OUR CAPABILITIES
Built to manufacture, not just to invent.
Unlike many platform-technology companies, EncapSolutions owns its core manufacturing step — the proprietary electrospinning process that produces the SkinSync® nanofibre mat — in house, in Sydney, in our own certified cleanroom.
Our Facilities
A dedicated chemical laboratory with full physical and chemical characterisation equipment, plus an ISO 14644-1 Class 7 cleanroom operated under our ISO 9001 quality management system.
Multidisciplinary Team
Biologists, chemists, chemical engineers, pharmacists, and material scientists working alongside carefully vetted local and international manufacturing partners.
Manufacturing Scale
Our electrospinning line produces nanofibre mat at industrial scale — more than one patch's worth per second — with finished patch assembly and packaging performed by specialist partner manufacturers.
Quality Commitment
We produce the critical components of the patch in house under our ISO 9001 quality management system, ensuring full traceability and consistency as we scale toward pharmaceutical-grade manufacturing.
OUR PHILOSOPHY
Smarter Innovation for a Better Life.
What looks like a simple patch has been fourteen years in the making. The idea behind SkinSync® was born in 2012 at a nanotechnology conference in Dresden, from a simple observation: most patches on the market waste a large portion of their active ingredient. What followed was a long, non-linear journey — across countries, through multiple material iterations, technical setbacks, and the hard choice between a long pharmaceutical pathway and bringing something to people sooner.
In 2022, that decision became EncapSolutions: a team committed to taking the technology out of the lab and into real life. We've since built the core nanofibre platform, refined multiple patch generations, established our own production capability, and brought SkinSync® to shelves and screens across the U.S. But the technology was never the point.
The question we hold ourselves to is simpler than that: does it help people feel better? Fourteen years on, watching that answer start to become "yes" is what keeps this team going — and we're just getting started.
OUR VALUES
The principles behind every decision.
PARTNERSHIP OPPORTUNITIES
Want to learn more about our team and capabilities?
Connect with the EncapSolutions team to discuss partnership, licensing, or collaboration.